P-1083. Implementation of a Sustainable Process for Mupirocin Decolonization across Adult ICUs in an Urban Safety Net Hospital
Angela L Cramer, Mary R Bartkus, Alison L Nelson, Rebecca Rudel, Jacqueline Steiner, Patricia Green, Astride Barnard, Sherine Henry, Michelle Betances, Cassandra Pierre, Tamar F Barlam

TL;DR
This study tested strategies to improve mupirocin use for MRSA decolonization in adult ICUs, finding that direct messaging providers was most effective and sustainable.
Contribution
The study identifies a sustainable, effective strategy for MRSA decolonization using direct messaging to maintain high mupirocin ordering rates.
Findings
Direct messaging of first call providers in phase three achieved >95% mupirocin ordering rates across all ICUs.
During the washout phase, mupirocin ordering rates remained above 85% for all but two weeks.
The most effective strategy was direct messaging, with no need for further active interventions to sustain target rates.
Abstract
Our hospital observed a significant increase in hospital-acquired MRSA bacteremia during 2023 and 2024 with half of these cases occurring in the adult ICUs. The benefit of MRSA decolonization on infection rates and the efficacy of mupirocin as a decolonization agent are well-documented. We tested a set of implementation strategies to improve the mupirocin ordering rate in the adult ICUs. The goal of this implementation study was to determine an effective, sustainable strategy for universal nasal decolonization across ICUs.Table 1.Percentage of Patients Ordered for Mupirocin across All ICUsTable shows how mupirocin was ordered across all adult ICUs during the three implementation phases and washout. Mupirocin was either ordered on admission via one of the admission order sets, ordered within 48 hours of the patient's ICU stay as an individual order, or not ordered. If the patient was not…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntimicrobial Resistance in Staphylococcus · Nosocomial Infections in ICU · Antibiotic Use and Resistance
